|
|
Taiwan Academic Institutional Repository >
Browse by Author
|
"yen ting lin"
Showing items 6-30 of 73 (3 Page(s) Totally)
1 2 3 > >>
View [10|25|50] records per page
| 臺大學術典藏 |
2021-11-29T06:46:17Z |
The Association between Glomerular Hyperfiltration and Left Ventricular Structure and Function in Patients with Primary Aldosteronism
|
Liao, Min-Tsun; Wu, Xue-Ming; Chang, Chin-Chen; Liao, Che-Wei; Chen, Ying-Hsien; Lu, Ching-Chu; YEN-TING LIN; Chang, Yi-Yao; Hung, Chi-Sheng; Lin, Lung-Chun; Lai, Chao-Lun; Lin, Lian-Yu; Wu, Vin-Cent; Ho, Yi-Lwun; Wu, Kwan-Dun; Lin, Yen-Hung |
| 臺大學術典藏 |
2021-11-29T06:45:12Z |
Plasma zinc alpha2-glycoprotein levels correlate positively with frailty severity in female elders
|
Lee, Ya-Ping; Chang, Chin-Hao; Liu, Heng-Hsiu; Chen, Chin-Ying; Chen, Ching-Yu; Hsu, Chih-Cheng; Chang, Ching-I; YEN-TING LIN; Lee, Chung-Sheng; Tsai, Jaw-Shiun |
| 臺大學術典藏 |
2021-11-29T06:44:11Z |
Effects of 12 weeks of atorvastatin therapy on myocardial fibrosis and circulating fibrosis biomarkers in statin-naïve patients with hypertension with atherosclerosis
|
Chang, Yi-Yao; Wu, Yen-Wen; Lee, Jen-Kuang; Lin, Yu-Min; YEN-TING LIN; Kao, Hsian-Li; Hung, Chi-Sheng; Lin, Hung-Ju; Lin, Yen-Hung |
| 臺大學術典藏 |
2021-11-29T06:37:51Z |
An International Real-World Analysis of the Efficacy and Safety of Lorlatinib Through Early or Expanded Access Programs in Patients With Tyrosine Kinase Inhibitor-Refractory ALK-Positive or ROS1-Positive NSCLC
|
Zhu, Viola W; YEN-TING LIN; Kim, Dong-Wan; Loong, Herbert H; Nagasaka, Misako; To, Hao; Ang, Yvonne Li-En; Ock, Chan-Young; Tchekmedyian, Nishan; Ou, Sai-Hong Ignatius; Syn, Nicholas L; Reungwetwattana, Thanyanan; Lin, Chia-Chi; Soo, Ross A |
| 臺大學術典藏 |
2021-11-29T06:36:34Z |
Not All EGFR Exon 20 Insertions Are Created Equal
|
YEN-TING LIN; Shih, Jin-Yuan |
| 臺大學術典藏 |
2021-11-29T06:35:37Z |
The relative importance of predictive factors for single first-generation EGFR-TKI use for more than 5 years in patients with advanced non-small cell lung cancer: Taiwan multicenter TIPS-5 study
|
Huang, Yen-Hsiang; Hung, Jen-Yu; Ko, How-Wen; Su, Po-Lan; Lai, Chun-Liang; Chang, Huang-Chih; Hsia, Te-Chun; Lin, Sheng-Hao; Wu, Kuan-Li; Yang, Cheng-Ta; Su, Wu-Chou; Chu, Yi-Chun; Wang, Chin-Chou; Liao, Wei-Yu; YEN-TING LIN; Lin, Ching-Hsiung; Lin, Meng-Chih; Hsu, Kuo-Hsuan; Tseng, Jeng-Sen; Yang, Tsung-Ying; Chen, Kun-Chieh; Lee, Mei-Hsuan; Yu, Sung-Liang; Ho, Chao-Chi; Chang, Gee-Chen |
| 臺大學術典藏 |
2021-11-29T06:31:55Z |
Resistance profiles of anaplastic lymphoma kinase tyrosine kinase inhibitors in advanced non-small-cell lung cancer: a multicenter study using targeted next-generation sequencing
|
YEN-TING LIN; Chiang, Chi-Lu; Hung, Jen-Yu; Lee, Mei-Hsuan; Su, Wu-Chou; Wu, Shang-Yin; Wei, Yu-Feng; Lee, Kang-Yun; Tseng, Yen-Han; Su, Jian; Chung, Hsin-Pei; Lin, Chih-Bin; Ku, Wen-Hui; Chiang, Tsai-Shin; Chiu, Chao-Hua; Shih, Jin-Yuan |
| 臺大學術典藏 |
2021-09-14T23:18:57Z |
Resistance profiles of anaplastic lymphoma kinase tyrosine kinase inhibitors in advanced non–small-cell lung cancer: a multicenter study using targeted next-generation sequencing
|
YEN-TING LIN; Chiang, Chi Lu; Hung, Jen Yu; Lee, Mei Hsuan; Su, Wu Chou; Wu, Shang Yin; Wei, Yu Feng; Lee, Kang Yun; Tseng, Yen Han; Su, Jian; Chung, Hsin Pei; Lin, Chih Bin; Ku, Wen Hui; Chiang, Tsai Shin; Chiu, Chao Hua; JIN-YUAN SHIH |
| 臺大學術典藏 |
2021-08-15T00:08:18Z |
Not All EGFR Exon 20 Insertions Are Created Equal
|
YEN-TING LIN; JIN-YUAN SHIH |
| 臺大學術典藏 |
2021-07-15T05:32:30Z |
First record of the invasive biofouling mussel mytella strigata (Hanley, 1843) (bivalvia: Mytilidae) from clam ponds in taiwan
|
Huang, Yi Cheng; Li, Ze Kai; WEN-LING CHEN; CHANG-CHUAN CHAN; Hsu, Hsiang Yi; YEN-TING LIN; Huang, Ying Sheng; YU-SAN HAN |
| 臺大學術典藏 |
2021-07-15T05:31:53Z |
The relative importance of predictive factors for single first-generation EGFR-TKI use for more than 5 years in patients with advanced non-small cell lung cancer: Taiwan multicenter TIPS-5 study
|
Huang, Yen Hsiang; Hung, Jen Yu; Ko, How Wen; Su, Po Lan; Lai, Chun Liang; Chang, Huang Chih; Hsia, Te Chun; Lin, Sheng Hao; Wu, Kuan Li; JUSTIN CHENG-TA YANG; Su, Wu Chou; Chu, Yi Chun; Wang, Chin Chou; WEI-YU LIAO; YEN-TING LIN; Lin, Ching Hsiung; Lin, Meng Chih; Hsu, Kuo Hsuan; Tseng, Jeng Sen; Yang, Tsung Ying; Chen, Kun Chieh; Lee, Mei Hsuan; SUNG-LIANG YU; CHAO-CHI HO; Chang, Gee Chen |
| 臺大學術典藏 |
2021-05-02T02:59:41Z |
The Association between Glomerular Hyperfiltration and Left Ventricular Structure and Function in Patients with Primary Aldosteronism
|
Liao, Min-Tsun; Wu, Xue-Ming; CHIN-CHEN CHANG; Liao, Che-Wei; Chen, Ying-Hsien; Lu, Ching-Chu; YEN-TING LIN; Chang, Yi-Yao; Hung, Chi-Sheng; Lin, Lung-Chun; Lai, Chao-Lun; Lin, Lian-Yu; Wu, Vin-Cent; Ho, Yi-Lwun; Wu, Kwan-Dun; Lin, Yen-Hung |
| 臺大學術典藏 |
2021-05-02T02:58:15Z |
MiR-200c-3p suppression is associated with development of acquired resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in EGFR mutant non-small cell lung cancer via a mediating epithelial-to-mesenchymal transition (EMT) process
|
Wang, Hsin-Yi; Liu, Yi-Nan; Wu, Shang-Gin; Hsu, Chia-Lang; Chang, Tzu-Hua; Tsai, Meng-Feng; YEN-TING LIN; Shih, Jin-Yuan |
| 臺大學術典藏 |
2020-05-25T01:33:01Z |
Development of renal cysts after crizotinib treatment in advanced ALK-positive non-small-cell lung cancer
|
YEN-TING LIN; Wang Y.-F.; Yang J.C.-H.; Yu C.-J.; Wu S.-G.; Shih J.-Y.; Yang P.-C. |
| 臺大學術典藏 |
2020-05-25T01:33:00Z |
Anaplastic Lymphoma Kinase (ALK) Kinase Domain Mutation Following ALK Inhibitor(s) Failure in Advanced ALK Positive Non–Small-Cell Lung Cancer: Analysis and Literature Review
|
YEN-TING LIN; Yu C.-J.; Yang J.C.-H.; Shih J.-Y. |
| 臺大學術典藏 |
2020-05-25T01:32:59Z |
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor-sensitive Exon 19 Insertion and Exon 20 Insertion in Patients With Advanced Non–Small-cell Lung Cancer
|
YEN-TING LIN; Liu Y.-N.; Wu S.-G.; Yang J.C.-H.; Shih J.-Y. |
| 臺大學術典藏 |
2020-05-25T01:32:59Z |
Transthoracic Ultrasound Elastography in Pulmonary Lesions and Diseases
|
Lim C.-K.; Chung C.-L.; YEN-TING LIN; Chang C.-H.; Lai Y.-C.; Wang H.-C.; Yu C.-J. |
| 臺大學術典藏 |
2020-05-25T01:32:58Z |
Validation of immunohistochemistry for the detection of BRAF V600E-mutated lung adenocarcinomas
|
Gow C.-H.; Hsieh M.-S.; YEN-TING LIN; Liu Y.-N.; Shih J.-Y. |
| 臺大學術典藏 |
2020-05-25T01:32:58Z |
Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations
|
YEN-TING LIN; Chen J.-S.; Liao W.-Y.; Ho C.-C.; Hsu C.-L.; Yang C.-Y.; Chen K.-Y.; Lee J.-H.; Lin Z.-Z.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2020-05-25T01:32:58Z |
Outcome of untreated lung nodules with histological but no microbiological evidence of tuberculosis 11 Medical and Health Sciences 1103 Clinical Sciences
|
Chung C.-L.; Chen Y.-F.; YEN-TING LIN; Wang J.-Y.; Kuo S.-W.; Chen J.-S. |
| 臺大學術典藏 |
2020-05-25T01:32:57Z |
Diagnosis of mediastinal tuberculous lymphadenitis using endobronchial ultrasound-guided transbronchial needle aspiration with rinse fluid polymerase chain reaction
|
Lin C.-K.; Keng L.-T.; Lim C.-K.; YEN-TING LIN; Lin S.-Y.; Chen L.-Y.; Yao Z.-H.; Chen Y.-H.; Ho C.-C. |
| 臺大學術典藏 |
2020-05-25T01:32:56Z |
Complex EGFR mutations with secondary T790M mutation confer shorter osimertinib progression-free survival and overall survival in advanced non-small cell lung cancer
|
Shih J.-Y.;Yu C.-J.;Liu Y.-N.;Wu S.-G.;Tsai T.-H.;YEN-TING LIN; YEN-TING LIN; Tsai T.-H.; Wu S.-G.; Liu Y.-N.; Yu C.-J.; Shih J.-Y. |
| 臺大學術典藏 |
2020-05-20T05:33:08Z |
MiR-200c-3p suppression is associated with development of acquired resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in EGFR mutant non-small cell lung cancer via a mediating epithelial-to-mesenchymal transition (EMT) process
|
JIN-YUAN SHIH;YEN-TING LIN;Tsai, Meng-Feng;Chang, Tzu-Hua;HSU, CHIA-LANG;Wu, Shang-Gin;Liu, Yi-Nan;Wang, Hsin-Yi; Wang, Hsin-Yi; Liu, Yi-Nan; Wu, Shang-Gin; HSU, CHIA-LANG; Chang, Tzu-Hua; Tsai, Meng-Feng; YEN-TING LIN; JIN-YUAN SHIH |
| 臺大學術典藏 |
2020-05-20T05:27:09Z |
Real-World Crizotinib Use for Anaplastic Lymphoma Kinase (ALK)-Positive Advanced Non-Small Cell Lung Cancer under First-Year National Health Insurance Coverage in Taiwan
|
JIN-YUAN SHIH;CHUNG-YU CHEN;YEN-TING LIN; YEN-TING LIN; CHUNG-YU CHEN; JIN-YUAN SHIH |
| 臺大學術典藏 |
2020-05-20T05:11:45Z |
Development of renal cysts after crizotinib treatment in advanced ALK-positive non-small-cell lung cancer
|
Wu S.-G.; Shih J.-Y.; Yang P.-C.; Yu C.-J.; Yang J.C.-H.; Wang Y.-F.; YEN-TING LIN; Yang P.-C.;Shih J.-Y.;Wu S.-G.;Yu C.-J.;Yang J.C.-H.;Wang Y.-F.;YEN-TING LIN |
Showing items 6-30 of 73 (3 Page(s) Totally)
1 2 3 > >>
View [10|25|50] records per page
|
